IBDEI2TY ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45141,1,4,0)
 ;;=4^D04.71
 ;;^UTILITY(U,$J,358.3,45141,2)
 ;;=^5001922
 ;;^UTILITY(U,$J,358.3,45142,0)
 ;;=D04.72^^170^2249^8
 ;;^UTILITY(U,$J,358.3,45142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45142,1,3,0)
 ;;=3^Carcinoma in Situ Skin Left Lower Limb
 ;;^UTILITY(U,$J,358.3,45142,1,4,0)
 ;;=4^D04.72
 ;;^UTILITY(U,$J,358.3,45142,2)
 ;;=^5001923
 ;;^UTILITY(U,$J,358.3,45143,0)
 ;;=D04.8^^170^2249^12
 ;;^UTILITY(U,$J,358.3,45143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45143,1,3,0)
 ;;=3^Carcinoma in Situ Skin Other Sites
 ;;^UTILITY(U,$J,358.3,45143,1,4,0)
 ;;=4^D04.8
 ;;^UTILITY(U,$J,358.3,45143,2)
 ;;=^5001924
 ;;^UTILITY(U,$J,358.3,45144,0)
 ;;=L72.0^^170^2249^42
 ;;^UTILITY(U,$J,358.3,45144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45144,1,3,0)
 ;;=3^Cyst,Epidermal
 ;;^UTILITY(U,$J,358.3,45144,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,45144,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,45145,0)
 ;;=L72.11^^170^2249^44
 ;;^UTILITY(U,$J,358.3,45145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45145,1,3,0)
 ;;=3^Cyst,Pilar
 ;;^UTILITY(U,$J,358.3,45145,1,4,0)
 ;;=4^L72.11
 ;;^UTILITY(U,$J,358.3,45145,2)
 ;;=^5009278
 ;;^UTILITY(U,$J,358.3,45146,0)
 ;;=L72.12^^170^2249^46
 ;;^UTILITY(U,$J,358.3,45146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45146,1,3,0)
 ;;=3^Cyst,Trichodermal
 ;;^UTILITY(U,$J,358.3,45146,1,4,0)
 ;;=4^L72.12
 ;;^UTILITY(U,$J,358.3,45146,2)
 ;;=^5009279
 ;;^UTILITY(U,$J,358.3,45147,0)
 ;;=L72.3^^170^2249^45
 ;;^UTILITY(U,$J,358.3,45147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45147,1,3,0)
 ;;=3^Cyst,Sebaceous
 ;;^UTILITY(U,$J,358.3,45147,1,4,0)
 ;;=4^L72.3
 ;;^UTILITY(U,$J,358.3,45147,2)
 ;;=^5009281
 ;;^UTILITY(U,$J,358.3,45148,0)
 ;;=A63.0^^170^2249^38
 ;;^UTILITY(U,$J,358.3,45148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45148,1,3,0)
 ;;=3^Condyloma
 ;;^UTILITY(U,$J,358.3,45148,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,45148,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,45149,0)
 ;;=L84.^^170^2249^1
 ;;^UTILITY(U,$J,358.3,45149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45149,1,3,0)
 ;;=3^Callus
 ;;^UTILITY(U,$J,358.3,45149,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,45149,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,45150,0)
 ;;=L03.314^^170^2249^24
 ;;^UTILITY(U,$J,358.3,45150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45150,1,3,0)
 ;;=3^Cellulitis of Groin
 ;;^UTILITY(U,$J,358.3,45150,1,4,0)
 ;;=4^L03.314
 ;;^UTILITY(U,$J,358.3,45150,2)
 ;;=^5009050
 ;;^UTILITY(U,$J,358.3,45151,0)
 ;;=A63.0^^170^2249^39
 ;;^UTILITY(U,$J,358.3,45151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45151,1,3,0)
 ;;=3^Condyloma
 ;;^UTILITY(U,$J,358.3,45151,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,45151,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,45152,0)
 ;;=M71.30^^170^2249^41
 ;;^UTILITY(U,$J,358.3,45152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45152,1,3,0)
 ;;=3^Cyst,Digital Mucous
 ;;^UTILITY(U,$J,358.3,45152,1,4,0)
 ;;=4^M71.30
 ;;^UTILITY(U,$J,358.3,45152,2)
 ;;=^5013149
 ;;^UTILITY(U,$J,358.3,45153,0)
 ;;=D04.122^^170^2249^7
 ;;^UTILITY(U,$J,358.3,45153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45153,1,3,0)
 ;;=3^Carcinoma in Situ Skin Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,45153,1,4,0)
 ;;=4^D04.122
 ;;^UTILITY(U,$J,358.3,45153,2)
 ;;=^5157285
 ;;^UTILITY(U,$J,358.3,45154,0)
 ;;=D04.121^^170^2249^9
 ;;^UTILITY(U,$J,358.3,45154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45154,1,3,0)
 ;;=3^Carcinoma in Situ Skin Left Upper Eyelid
